Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bronchioloalveolar Cancer”

19 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 19 results

Testing effectiveness (Phase 2)Ended earlyNCT00074295
What this trial is testing

S0310: Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Bronchoalveolar Lung Cancer

Who this might be right for
Lung Cancer
SWOG Cancer Research Network 19
Testing effectiveness (Phase 2)Study completedNCT00588445
What this trial is testing

Phase II Trial to Correlate Radiographic Response Induced By Gefitinib With Mutations in the Protein-Tyrosine Kinase Domain of the EGF Receptor Gene

Who this might be right for
Lung CancerNon-small Cell Lung CancerBronchioloalveolar Cancer
Memorial Sloan Kettering Cancer Center 65
Testing effectiveness (Phase 2)Ended earlyNCT00955305
What this trial is testing

Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer

Who this might be right for
Large Cell Lung CarcinomaLung AdenocarcinomaRecurrent Non-Small Cell Lung Carcinoma+2 more
National Cancer Institute (NCI) 175
Testing effectiveness (Phase 2)Study completedNCT00590902
What this trial is testing

Ph II OSI-774 (Erlotinib,Tarceva) In Advanced Bronchioloalveolar Cell Lung Cancer

Who this might be right for
Bronchioloalveolar Cell Variant of Non-small Cell Lung Cancer
Memorial Sloan Kettering Cancer Center 81
Testing effectiveness (Phase 2)Study completedNCT02186847
What this trial is testing

Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer

Who this might be right for
Adenosquamous Lung CarcinomaBronchioloalveolar CarcinomaLarge Cell Lung Carcinoma+6 more
NRG Oncology 170
Testing effectiveness (Phase 2)Ended earlyNCT00265785
What this trial is testing

S0526: Pemetrexed Disodium in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
SWOG Cancer Research Network 27
Early research (Phase 1)Study completedNCT00003649
What this trial is testing

Gene Therapy in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Surgically Removed

Who this might be right for
Lung Cancer
Eastern Cooperative Oncology Group
Not applicableStudy completedNCT02357992
What this trial is testing

Lung Cancer STARS Trial - STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 122
Testing effectiveness (Phase 2)Study completedNCT01294306
What this trial is testing

MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy

Who this might be right for
Adenosquamous Lung CarcinomaBronchioloalveolar CarcinomaLarge Cell Lung Carcinoma+3 more
National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Study completedNCT00950365
What this trial is testing

Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Bronchioloalveolar CarcinomaLarge Cell Lung CarcinomaLung Adenocarcinoma+3 more
Albert Einstein College of Medicine 79
Testing effectiveness (Phase 2)Ended earlyNCT00117351
What this trial is testing

VELCADE in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC Features

Who this might be right for
Carcinoma, Non-Small-Cell LungAdenocarcinoma, Bronchiolo-Alveolar
Millennium Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT00073008
What this trial is testing

Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 131
Testing effectiveness (Phase 2)Ended earlyNCT01511081
What this trial is testing

Stereotactic Body Radiotherapy (SBRT) Versus Stereotactic Body Proton Therapy (SBPT)

Who this might be right for
Non-small-cell Lung Cancer
M.D. Anderson Cancer Center 21
Testing effectiveness (Phase 2)Study completedNCT00198380
What this trial is testing

Treatment of Lung Adenocarcinoma With Bronchioloalveolar Feature

Who this might be right for
Pneumonic-type Adenocarcinoma (P-ADC)Lung Adenocarcinoma With Bronchiolo-alveolar Feature
Intergroupe Francophone de Cancerologie Thoracique 90
Testing effectiveness (Phase 2)Study completedNCT00029003
What this trial is testing

Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Bronchoalveolar Cell Lung CancerRecurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer+1 more
National Cancer Institute (NCI) 90
Testing effectiveness (Phase 2)Study completedNCT00002969
What this trial is testing

S9714: Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
SWOG Cancer Research Network 60
Testing effectiveness (Phase 2)Study completedNCT00384826
What this trial is testing

Therapeutic Strategy in Advanced Bronchioloalveolar Carcinoma

Who this might be right for
Adenocarcinoma, Bronchiolo-Alveolar
Intergroupe Francophone de Cancerologie Thoracique 133
Not applicableLooking for participantsNCT05671887
What this trial is testing

DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies

Who this might be right for
Lung CancerBilateral CancerLung Transplant
Northwestern University 125
Testing effectiveness (Phase 2)Study completedNCT00436332
What this trial is testing

S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma

Who this might be right for
Lung Cancer
SWOG Cancer Research Network 84